Tag: Predicta Biosciences

Predicta Biosciences Secures $23.4M to Scale its Novel Diagnostic and Analytics Platform for Blood Cancers and Autoimmune Diseases

Predicta Biosciences Secures $23.4M to Scale its Novel Diagnostic and Analytics Platform for Blood Cancers and Autoimmune Diseases

Brian McKernan joins as CEO to further advance Predicta’s clinical impact, including its non-invasive diagnostic for Multiple Myeloma CAMBRIDGE, Mass.–(BUSINESS WIRE)–Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic discovery solutions, today announced…

Read More Read More

Predicta Biosciences Secures $5.2M to Transform the Diagnosis, Treatment and Monitoring of Blood Cancers

Predicta Biosciences Secures $5.2M to Transform the Diagnosis, Treatment and Monitoring of Blood Cancers

Founded by leading cancer genomics researchers and clinicians, Predicta is developing a novel, non-invasive diagnostic for Multiple Myeloma Predicta Biosciences team (Photo: Business Wire) July 16, 2024 05:00 AM Pacific Daylight Time BOSTON–(BUSINESS WIRE)–Predicta Biosciences,…

Read More Read More